Illumina, Inc.
ILMN Healthcare Diagnostics & Research
Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024. In the quarter to June 2026, revenue grew 9.44%, EPS fell 8.05%, free cash flow fell 18.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
Follow ILMN
Illumina, Inc. (ILMN) Revenue growth
Illumina, Inc.'s revenue growth over the twelve months to 30 June 2026 was 4.88%, up 5.5 percentage points from fiscal 2025 (−0.66%). Over the past ten years it has ranged from −8.58% (fiscal 2020) to 39.7% (fiscal 2021); the current reading is higher than 36% of that period. That is below the Diagnostics & Research industry median of 7.69% and below the Healthcare sector median of 8.27%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | −0.66% | 2.27 |
| FY2024 | −2.93% | (1.18) |
| FY2023 | −1.75% | (3.03) |
| FY2022 | 1.28% | (38.45) |
| FY2021 | 39.7% | 48.31 |
| FY2020 | −8.58% | (14.88) |
| FY2019 | 6.30% | (14.81) |
| FY2018 | 21.1% | 6.35 |
| FY2017 | 14.8% | 6.74 |
| FY2016 | 8.02% | (11.25) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 9.44% | 4.64 |
| Mar 2026 | 4.80% | (0.18) |
| Dec 2025 | 4.98% | 4.61 |
| Sep 2025 | 0.37% | 5.14 |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| WAT Waters Corporation compare | 52.5% |
| NTRA Natera, Inc. compare | 37.8% |
| IDXX IDEXX Laboratories, Inc. compare | 12.8% |
| DGX Quest Diagnostics Incorporated compare | 9.87% |
| A Agilent Technologies, Inc. compare | 8.60% |
| IQV IQVIA Holdings Inc. compare | 8.17% |
| MTD Mettler-Toledo International, Inc. compare | 6.91% |
| LH Labcorp Holdings Inc. compare | 6.41% |
| ILMN Illumina, Inc. | 4.88% |
| Diagnostics & Research industry median | 7.69% |
| Healthcare sector median | 8.27% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on ILMN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement